N6-Methyladenosine Contributes to Cellular Phenotype in a Genetically-Defined Model of Breast Cancer Progression

Oncotarget - United States
doi 10.18632/oncotarget.25782
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Changes of N6-Methyladenosine Modulators Promote Breast Cancer Progression

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

N6-Methyladenosine Links RNA Metabolism to Cancer Progression

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

N6-Methyladenosine: A Novel RNA Imprint in Human Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

N6-Methyladenosine Modification of ITGA6 mRNA Promotes the Development and Progression of Bladder Cancer

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

METTL14 Suppresses Colorectal Cancer Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2020English

CD155 Contributes to the Mesenchymal Phenotype of Triple‐negative Breast Cancer

Cancer Science
Cancer ResearchMedicineOncology
2020English

A Developmentally Regulated Inducer of EMT, LBX1, Contributes to Breast Cancer Progression

Genes and Development
GeneticsDevelopmental Biology
2009English

Phasing Gene Expression: mRNA N6-Methyladenosine Regulates Temporal Progression of Mammalian Cortical Neurogenesis

Biochemistry
Biochemistry
2018English

Cellular Plasticity in Breast Cancer Progression and Therapy

Frontiers in Molecular Biosciences
BiochemistryGeneticsMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy